Certainly Commendable but Perhaps not Practical – Canada’s Competition Bureau Releases Guidelines on Pharmaceutical Patent Litigation Settlements

On September 23, Canada’s Competition Bureau (“the Bureau”) announced  landmark guidelines regarding the consideration of pharmaceutical patent litigation settlements under Canada’s competition law framework. The Bureau’s guidelines on this issue…

CETA: A Very Reasonable Canadian-esque Compromise on Pharmaceutical Intellectual Property Law Changes

At long last, the Canadian Federal Government and the European Commission announced in October that a political agreement has been reached regarding the much anticipated Comprehensive Economic and Trade Agreement…